Fidelity Investments’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$176K Sell
60,748
-1,551
-2% -$3.31K ﹤0.01% 3551
2025
Q4
$100K Sell
62,299
-1,035
-2% -$1.63K ﹤0.01% 3753
2025
Q3
$106K Sell
63,334
-581
-0.9% -$940 ﹤0.01% 3638
2025
Q2
$77.3K Sell
63,915
-184,320
-74% -$267K ﹤0.01% 3710
2025
Q1
$315K Buy
248,235
+73,739
+42% +$193K ﹤0.01% 3072
2024
Q4
$567K Buy
174,496
+37,281
+27% +$134K ﹤0.01% 2877
2024
Q3
$451K Buy
137,215
+126,899
+1,230% +$494K ﹤0.01% 2903
2024
Q2
$43.8K Sell
10,316
-65,189
-86% -$635K ﹤0.01% 3680
2024
Q1
$1.11M Sell
75,505
-11,583
-13% -$175K ﹤0.01% 2476
2023
Q4
$838K Sell
87,088
-1,223
-1% -$8.46K ﹤0.01% 2524
2023
Q3
$412K Sell
88,311
-1,094
-1% -$5.45K ﹤0.01% 2677
2023
Q2
$478K Buy
89,405
+22,508
+34% +$139K ﹤0.01% 2673
2023
Q1
$480K Buy
66,897
+58,420
+689% +$352K ﹤0.01% 2701
2022
Q4
$56.9K Sell
8,477
-223,279
-96% -$1.22M ﹤0.01% 3399
2022
Q3
$802K Sell
231,756
-164,993
-42% -$631K ﹤0.01% 2662
2022
Q2
$1.17M Sell
396,749
-476,939
-55% -$2.51M ﹤0.01% 2639
2022
Q1
$7.7M Sell
873,688
-376,793
-30% -$4.16M ﹤0.01% 2226
2021
Q4
$20.1M Sell
1,250,481
-398,554
-24% -$7.5M ﹤0.01% 1823
2021
Q3
$34.5M Sell
1,649,035
-254,836
-13% -$6.14M ﹤0.01% 1585
2021
Q2
$51.1M Buy
1,903,871
+37,811
+2% +$1.11M ﹤0.01% 1417
2021
Q1
$59.4M Buy
1,866,060
+653,738
+54% +$15.9M 0.01% 1313
2020
Q4
$27.7M Buy
1,212,322
+36,982
+3% +$851K ﹤0.01% 1571
2020
Q3
$29.6M Buy
1,175,340
+691,988
+143% +$18.9M ﹤0.01% 1407
2020
Q2
$13.5M Sell
483,352
-98,691
-17% -$1.71M ﹤0.01% 1703
2020
Q1
$3.39M Sell
582,043
-248,400
-30% -$2.26M ﹤0.01% 2053
2019
Q4
$9.04M Sell
830,443
-267,100
-24% -$2.64M ﹤0.01% 1884
2019
Q3
$14M Sell
1,097,543
-185,000
-14% -$2.66M ﹤0.01% 1709
2019
Q2
$21.8M Sell
1,282,543
-275,188
-18% -$4.73M ﹤0.01% 1593
2019
Q1
$28M Sell
1,557,731
-504,900
-24% -$8.73M ﹤0.01% 1446
2018
Q4
$26.2M Sell
2,062,631
-557,580
-21% -$9.35M ﹤0.01% 1447
2018
Q3
$56.2M Sell
2,620,211
-420,983
-14% -$8.97M 0.01% 1216
2018
Q2
$62.8M Sell
3,041,194
-369,841
-11% -$8.33M 0.01% 1170
2018
Q1
$85.8M Sell
3,411,035
-228,502
-6% -$5.55M 0.01% 1045
2017
Q4
$69.2M Sell
3,639,537
-764,987
-17% -$14.3M 0.01% 1151
2017
Q3
$81.4M Sell
4,404,524
-834,393
-16% -$14.5M 0.01% 1068
2017
Q2
$91.7M Buy
5,238,917
+295,553
+6% +$5.64M 0.01% 1022
2017
Q1
$91.9M Sell
4,943,364
-281,994
-5% -$5.44M 0.01% 1023
2016
Q4
$107M Buy
5,225,358
+249,531
+5% +$6.28M 0.01% 960
2016
Q3
$149M Sell
4,975,827
-2,170
-0% -$64.5K 0.02% 797
2016
Q2
$134M Buy
4,977,997
+1,438,175
+41% +$32.4M 0.02% 841
2016
Q1
$66.4M Sell
3,539,822
-65,409
-2% -$1.25M 0.01% 1134
2015
Q4
$112M Buy
3,605,231
+116,149
+3% +$3.53M 0.02% 924
2015
Q3
$74.7M Buy
3,489,082
+277,040
+9% +$8.69M 0.01% 1081
2015
Q2
$122M Hold
3,212,042
0.02% 942
2015
Q1
$101M Hold
3,212,042
0.01% 1026
2014
Q4
$113M Hold
3,212,042
0.01% 954
2014
Q3
$67.1M Sell
3,212,042
-48,526
-1% -$1M 0.01% 1161
2014
Q2
$70.9M Buy
3,260,568
+1,300,826
+66% +$27.3M 0.01% 1188
2014
Q1
$54.5M Buy
1,959,742
+759,742
+63% +$26.8M 0.01% 1280
2013
Q4
$32.9M Buy
+1,200,000
New +$31.4M ﹤0.01% 1512

Other funds holding MGNX

Fidelity Investments's MGNX Position: Q1 2026 in Review

Fidelity Investments reduced its MacroGenics (MGNX) stake by 2.5% in Q1 2026, selling an estimated $3.31K and leaving 60,748 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #3551.

Fidelity Investments first reported a position in MGNX in Q4 2013 and has held it in 50 quarters since. The position peaked at $149M in Q3 2016. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Fidelity Investments held 60,748 shares of MacroGenics worth $176K as of Q1 2026.
  • Fidelity Investments sold 1,551 MacroGenics shares in Q1 2026, an estimated $3.31K.
  • MacroGenics made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #3551 holding.
  • Fidelity Investments first reported a position in MacroGenics in Q4 2013 and has held it in 50 quarters since.
  • Fidelity Investments's MacroGenics position peaked at $149M in Q3 2016.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.